Treating infectious diseases in a microbial world (Record no. 204546)
[ view plain ]
000 -LEADER | |
---|---|
fixed length control field | 02105nam a2200361Ia 4500 |
001 - CONTROL NUMBER | |
control field | EBC3378039 |
005 - DATE AND TIME OF LATEST TRANSACTION | |
control field | 20240121043956.0 |
006 - FIXED-LENGTH DATA ELEMENTS--ADDITIONAL MATERIAL CHARACTERISTICS | |
fixed length control field | m o d | |
007 - PHYSICAL DESCRIPTION FIXED FIELD--GENERAL INFORMATION | |
fixed length control field | cr cn||||||||| |
008 - FIXED-LENGTH DATA ELEMENTS--GENERAL INFORMATION | |
fixed length control field | 060111s2006 dcu sb 000 0 eng d |
020 ## - INTERNATIONAL STANDARD BOOK NUMBER | |
Canceled/invalid ISBN | 0309100569 |
035 ## - SYSTEM CONTROL NUMBER | |
System control number | (MiAaPQ)EBC3378039 |
035 ## - SYSTEM CONTROL NUMBER | |
System control number | (Au-PeEL)EBL3378039 |
035 ## - SYSTEM CONTROL NUMBER | |
System control number | (CaPaEBR)ebr10110304 |
035 ## - SYSTEM CONTROL NUMBER | |
System control number | (CaONFJC)MIL31005 |
035 ## - SYSTEM CONTROL NUMBER | |
System control number | (OCoLC)63665050 |
040 ## - CATALOGING SOURCE | |
Original cataloging agency | MiAaPQ |
Transcribing agency | MiAaPQ |
Modifying agency | MiAaPQ |
050 #4 - LIBRARY OF CONGRESS CALL NUMBER | |
Classification number | RM262 |
Item number | .T74 2006 |
110 2# - MAIN ENTRY--CORPORATE NAME | |
Corporate name or jurisdiction name as entry element | National Research Council (U.S.). |
Subordinate unit | Committee on New Directions in the Study of Antimicrobial Therapeutics: New Classes of Antimicrobials. |
245 10 - TITLE STATEMENT | |
Title | Treating infectious diseases in a microbial world |
Medium | [electronic resource] : |
Remainder of title | report of two workshops on novel antimicrobial therapeutics / |
Statement of responsibility, etc. | Committee on New Directions int he Study of Antimicrobial Therapeutics: New Classes of Antimicrobials [and] Committee on New Directions in the Study of Antimicrobial Therapeutics: Immunomodulation; Board on Life Sciences, Division on Earth and Life Studies, National Research Council of the National Academies. |
260 ## - PUBLICATION, DISTRIBUTION, ETC. | |
Place of publication, distribution, etc. | Washington, D.C. : |
Name of publisher, distributor, etc. | National Academies Press, |
Date of publication, distribution, etc. | 2006. |
300 ## - PHYSICAL DESCRIPTION | |
Extent | x, 92 p. |
504 ## - BIBLIOGRAPHY, ETC. NOTE | |
Bibliography, etc. note | Includes bibliographical references. |
505 0# - FORMATTED CONTENTS NOTE | |
Formatted contents note | Challenges for the development of new antimicrobials-rethinking the approaches: report of a workshop -- Promising approaches to the development of immunomodulation for the treatment of infectious diseases: report of a workshop. |
533 ## - REPRODUCTION NOTE | |
Type of reproduction | Electronic reproduction. Ann Arbor, MI : ProQuest, 2015. Available via World Wide Web. Access may be limited to ProQuest affiliated libraries. |
650 #0 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Anti-infective agents |
General subdivision | Therapeutic use. |
650 #0 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Communicable diseases |
General subdivision | Treatment. |
655 #4 - INDEX TERM--GENRE/FORM | |
Genre/form data or focus term | Electronic books. |
710 2# - ADDED ENTRY--CORPORATE NAME | |
Corporate name or jurisdiction name as entry element | National Research Council (U.S.). |
Subordinate unit | Committee on New Directions in the Study of Antimicrobial Therapeutics: Immunomodulation. |
710 2# - ADDED ENTRY--CORPORATE NAME | |
Corporate name or jurisdiction name as entry element | ProQuest (Firm) |
856 40 - ELECTRONIC LOCATION AND ACCESS | |
Uniform Resource Identifier | <a href="https://ebookcentral.proquest.com/lib/bacm-ebooks/detail.action?docID=3378039">https://ebookcentral.proquest.com/lib/bacm-ebooks/detail.action?docID=3378039</a> |
Public note | Click to View |
No items available.